TRICARE Expands Cancer Clinical Trials Demonstration

Publication
Article
OncologyONCOLOGY Vol 13 No 8
Volume 13
Issue 8

TRICARE, the health plan for active duty military personnel (formerly known as CHAMPUS), expanded its cancer clinical trials demonstration so that beneficiaries could enter cancer prevention trials sponsored by the National Cancer Institute

TRICARE, the health plan for active duty military personnel (formerly known as CHAMPUS), expanded its cancer clinical trials demonstration so that beneficiaries could enter cancer prevention trials sponsored by the National Cancer Institute (NCI). The demonstration had previously been limited to cancer treatment trials. The expansion, effective in June, was somewhat of a last-ditch effort to entice more TRICARE beneficiaries into the demonstration so that TRICARE could obtain more data on which to base future decisions. Between January 1996 and August 1998, only 155 TRICARE beneficiaries enrolled in NCI trials, and those were almost exclusively for bone marrow transplants.

Of course, TRICARE has a much better record on covering patient costs of participating in cancer clinical trials than almost any other health plan. Sens. Jay Rockefeller (D-W. Va.) and Connie Mack (R-Fla.) have been trying for years to persuade Congress to pass a bill authorizing a Medicare demonstration that would ensure coverage of patient care costs. No bill has ever gotten out of a Senate committee.

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content